Annual income exceeds 5 billion yuan, China's Artificial Intelligence General Hospital becomes the international leader in medical AI.

Recently, the large-scale medical model of WeDoctor topped two authoritative medical model evaluation lists, attracting widespread attention. With the wave of "AI+", competitions around large-scale medical models are heating up, but the commercialization challenge of AI healthcare remains a significant obstacle for the majority of technology startups. In this regard, WeDoctor's practice in Tianjin is leading the way in China and internationally. Senior observers point out that WeDoctor not only leads in the competition of cutting-edge technologies such as large-scale models, but also achieves remarkable results in practical application scenarios, making it a rare pioneer in the field of AI healthcare that has achieved a complete closed-loop system from top to bottom. With top three annual revenue, Tianjin Artificial Intelligence General Hospital delivers outstanding achievements In the wave of AI development, competition around large-scale models is ongoing, with authoritative evaluation platforms becoming the battleground for major technology companies to showcase their AI capabilities. Recently, the well-known Chinese medical large-scale model evaluation platform, MedBench, announced a new ranking list, where WeDoctor's large medical model with a total score of 94.7 points outperformed well-known models such as Ant Medical's and WiseDiag, becoming the leader in its self-test list. Moreover, in the past six months, its large-scale model has also topped multiple times in the authoritative medical model evaluation platform in China, making WeDoctor's medical model the champion of both lists. Apart from its technological prowess, external focus is on the implementation success of WeDoctor's AI healthcare services. By December 31, 2024, WeDoctor filed for an IPO with the Hong Kong Stock Exchange, with its impressive performance in Tianjin drawing attention According to the prospectus, from 2021 to 2023, WeDoctor's revenue was RMB 962 million, RMB 1.368 billion, and RMB 1.863 billion, respectively. In the first half of 2024, revenue reached RMB 1.818 billion, a 107.4% year-on-year increase, with revenue from AI medical services accounting for nearly 80%. Industry analysts analyze that the revenue from WeDoctor's AI medical services comes from the Tianjin AI General Hospital, meaning that the revenue from this AI hospital in the first half of 2024 has exceeded RMB 1.4 billion. The prospectus also highlights two noteworthy figures: as of June 30, 2024, the Tianjin AI hospital, as the core of the Digital Health Community, has a membership base of approximately 900,000 across multiple diseases and diabetes categories; from April 1 to June 30, 2024, the annual per capita quota for multi-disease types covered by Tianjin's medical insurance was approximately RMB 8,000. Industry insiders reveal that through AI empowerment of all primary medical institutions in the city and the formation of a community of shared capabilities, services, and benefits, the revenue of Tianjin's AI General Hospital has grown rapidly, making it one of the top three medical institutions in Tianjin in terms of total revenue in 2024, possibly exceeding RMB 5 billion. The success story of AI empowerment of Tianjin AI General Hospital is also a focal point in the market. Public data shows that, thanks to the deep application of the five intelligent bodies of "AI Doctor, AI Pharmacist, AI Examination, AI Health Manager, AI Intelligent Control" at the Tianjin AI General Hospital, medical services covering pre-diagnosis, diagnosis, and post-diagnosis processes have been improved in terms of quality and efficiency. In Tianjin, led by the AI General Hospital, a close-knit digital medical alliance has been established with 266 primary medical institutions, over 2,000 primary medical service stations, and health rooms in the city, taking over three years to achieve positive results in improving patient health indicators, enhancing primary service capabilities, and lowering medical insurance expenditure growth rates. Data indicates that from January 2023 to June 2024, the glycated hemoglobin levels of diabetic members under management at the primary care institutions improved from 17.8% to 44.2%, blood pressure control rates rose from 19.5% to 61.5%, and blood lipid control rates increased from 24.8% to 27.9%. The number of outpatient visits at primary care institutions increased significantly, with growth ranging from 23% to 50%. Similarly, medical insurance expenditure growth rates decreased significantly, with a surplus rate of over 25% for diabetic patients at primary care institutions cooperating with the Tianjin Health Alliance from January 2023 to June 2024. By empowering the AI General Hospital, relationships among the participants within Tianjin's Digital Health Community have been redefined, and the combination of "AI empowerment + health performance" is breaking through the global challenge of how the healthcare system can achieve "win-win-win-win" results: improving patient health, increasing doctor incomes, enhancing hospital capabilities and outpatient visits, and reducing the growth rate of medical insurance expenditures. The prospectus discloses that WeDoctor is replicating this model in multiple regions while also planning to collaborate with other participants in China's digital healthcare industry to establish a standardized evaluation system for AI hospitals in China. WeDoctor was the first to establish an internet hospital in China and successfully promoted the normative development of the internet healthcare industry. Currently, WeDoctor is actively working with various parties to create industry standards for medical AI, aiming to promote the standardized development of medical AI in China and align with international standards. It is foreseeable that in the upcoming transformation of the healthcare industry, the AI General Hospital is poised to play a crucial role. The experience of WeDoctor and Tianjin may create new miracles.